AVE5530

DRUG4 trials

Sponsors

Sanofi

Conditions

Hypercholesterolemia

Phase 2

A Study Evaluating the Safety and Efficacy of AVE5530 (4 Weeks) in Patients With Mild to Moderate Hypercholesterolemia

CompletedNCT00440154

SanofiHypercholesterolemia

Start: 2007-02-28End: 2007-10-31Updated: 2008-12-16

Phase 3

Evaluation of Efficacy and Safety of AVE5530 in Patients With Primary Hypercholesterolemia

TerminatedNCT00718965

SanofiHypercholesterolemia

Start: 2008-07-31End: 2009-06-30Updated: 2016-05-16

Evaluation of Efficacy and Safety of AVE5530 Co-administered With Atorvastatin in Primary Hypercholesterolemia

TerminatedNCT00741715

SanofiHypercholesterolemia

Start: 2008-08-31End: 2009-06-30Updated: 2016-05-16

Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing High Doses of Statins in Patients With Primary Severe Hypercholesterolemia

TerminatedNCT00766688

SanofiHypercholesterolemia

Start: 2008-10-31End: 2009-06-30Updated: 2016-05-16